1,877
Views
25
CrossRef citations to date
0
Altmetric
Research Papers

Open-label phase I clinical trial of Ad5-EBOV in Africans in China

, , , , , , , , , , , , , , , , , , , , , , , & show all
Pages 2078-2085 | Received 04 Apr 2017, Accepted 08 Jun 2017, Published online: 03 Aug 2017

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Keesha M. Matz, Andrea Marzi & Heinz Feldmann. (2019) Ebola vaccine trials: progress in vaccine safety and immunogenicity. Expert Review of Vaccines 18:12, pages 1229-1242.
Read now
Franck J. D. Mennechet, Océane Paris, Aline Raissa Ouoba, Sofia Salazar Arenas, Sodiomon B. Sirima, Guy R. Takoudjou Dzomo, Amidou Diarra, Isidore T Traore, Dramane Kania, Karsten Eichholz, Eric A. Weaver, Edouard Tuaillon & Eric J. Kremer. (2019) A review of 65 years of human adenovirus seroprevalence. Expert Review of Vaccines 18:6, pages 597-613.
Read now
Katie Ewer, Sarah Sebastian, Alexandra J. Spencer, Sarah Gilbert, Adrian V. S. Hill & Teresa Lambe. (2017) Chimpanzee adenoviral vectors as vaccines for outbreak pathogens. Human Vaccines & Immunotherapeutics 13:12, pages 3020-3032.
Read now

Articles from other publishers (22)

Hong-Qing Zhang, Qiu-Yan Zhang, Zhi-Ming Yuan & Bo Zhang. (2023) The potential epidemic threat of Ebola virus and the development of a preventive vaccine. Journal of Biosafety and Biosecurity 5:2, pages 67-78.
Crossref
Shen Wang, Bo Liang, Weiqi Wang, Ling Li, Na Feng, Yongkun Zhao, Tiecheng Wang, Feihu Yan, Songtao Yang & Xianzhu Xia. (2023) Viral vectored vaccines: design, development, preventive and therapeutic applications in human diseases. Signal Transduction and Targeted Therapy 8:1.
Crossref
Lauren Pischel, Kavin M Patel, George Goshua & Saad B Omer. (2022) Adenovirus-Based Vaccines and Thrombosis in Pregnancy: A Systematic Review and Meta-analysis. Clinical Infectious Diseases 75:7, pages 1179-1186.
Crossref
Pedro M Folegatti, Daniel Jenkin, Susan Morris, Sarah Gilbert, Denny Kim, James S. Robertson, Emily R. Smith, Emalee Martin, Marc Gurwith & Robert T. Chen. (2022) Vaccines based on the replication-deficient simian adenoviral vector ChAdOx1: Standardized template with key considerations for a risk/benefit assessment. Vaccine 40:35, pages 5248-5262.
Crossref
Naina McCann, Daniel O’Connor, Teresa Lambe & Andrew J Pollard. (2022) Viral vector vaccines. Current Opinion in Immunology 77, pages 102210.
Crossref
Pooyan Makvandi, Meiling Chen, Rossella Sartorius, Ali Zarrabi, Milad Ashrafizadeh, Farnaz Dabbagh Moghaddam, Jingzhi Ma, Virgilio Mattoli & Franklin R. Tay. (2021) Endocytosis of abiotic nanomaterials and nanobiovectors: Inhibition of membrane trafficking. Nano Today 40, pages 101279.
Crossref
Shen Wang, Ling Li, Feihu Yan, Yuwei Gao, Songtao Yang & Xianzhu Xia. (2021) COVID-19 Animal Models and Vaccines: Current Landscape and Future Prospects. Vaccines 9:10, pages 1082.
Crossref
Coralie F. Daussy, Noémie Pied & Harald Wodrich. (2021) Understanding Post Entry Sorting of Adenovirus Capsids; A Chance to Change Vaccine Vector Properties. Viruses 13:7, pages 1221.
Crossref
Yuehai Pan, Fei Gao, Shuai Zhao, Jinming Han & Fan Chen. (2021) Role of the SphK‐S1P‐S1PRs pathway in invasion of the nervous system by SARS‐CoV‐2 infection. Clinical and Experimental Pharmacology and Physiology 48:5, pages 637-650.
Crossref
Iqra Mehmood, Munazza Ijaz, Sajjad Ahmad, Temoor Ahmed, Amna Bari, Asma Abro, Khaled S. Allemailem, Ahmad Almatroudi & Muhammad Tahir ul Qamar. (2021) SARS-CoV-2: An Update on Genomics, Risk Assessment, Potential Therapeutics and Vaccine Development. International Journal of Environmental Research and Public Health 18:4, pages 1626.
Crossref
Hannah R. Sharpe, Ciaran Gilbride, Elizabeth Allen, Sandra Belij‐Rammerstorfer, Cameron Bissett, Katie Ewer & Teresa Lambe. (2020) The early landscape of coronavirus disease 2019 vaccine development in the UK and rest of the world. Immunology 160:3, pages 223-232.
Crossref
Letitia D. Jones, M. Anthony Moody & Amelia B. Thompson. (2020) Innovations in HIV-1 Vaccine Design. Clinical Therapeutics 42:3, pages 499-514.
Crossref
Yu Fang. (2020) An Overview of the Progress Made on the Coronavirus Vaccine. E3S Web of Conferences 185, pages 03042.
Crossref
Aitana Juan-Giner, Marie Tchaton, Jean-Paul Jemmy, Aboubacar Soumah, Yap Boum, Elisabetta Maria Faga, Mohamed Cisse & Rebecca F. Grais. (2019) Safety of the rVSV ZEBOV vaccine against Ebola Zaire among frontline workers in Guinea. Vaccine 37:48, pages 7171-7177.
Crossref
Sergei I. Bazhan, Denis V. Antonets, Larisa I. Karpenko, Svetlana F. Oreshkova, Olga N. Kaplina, Ekaterina V. Starostina, Sergei G. Dudko, Sofia A. Fedotova & Alexander A. Ilyichev. (2019) In silico Designed Ebola Virus T-Cell Multi-Epitope DNA Vaccine Constructions Are Immunogenic in Mice. Vaccines 7:2, pages 34.
Crossref
Shakti Singh, Rakesh Kumar & Babita Agrawal. 2019. Adenoviruses. Adenoviruses.
Andrea Marzi & Chad E. Mire. (2019) Current Ebola Virus Vaccine Progress. BioDrugs 33:1, pages 9-14.
Crossref
Helen H. Mao & Shoubai Chao. 2020. Current Applications of Pharmaceutical Biotechnology. Current Applications of Pharmaceutical Biotechnology 155 188 .
Yuhua LiLing WangTao ZhuShipo WuLiqiang FengPing ChengJingjing LiuJunzhi Wang. (2018) Establishing China's National Standard for the Recombinant Adenovirus Type 5 Vector–Based Ebola Vaccine (Ad5-EBOV) Virus Titer. Human Gene Therapy Clinical Development 29:4, pages 226-232.
Crossref
Kerrie Vaughan, Xiaojun Xu, Bjoern Peters & Alessandro Sette. (2018) Investigation of Outbreak-Specific Nonsynonymous Mutations on Ebolavirus GP in the Context of Known Immune Reactivity. Journal of Immunology Research 2018, pages 1-11.
Crossref
Qiu-dong Su, Shi-hua He, Yao Yi, Feng Qiu, Xue-xin Lu, Zhi-yuan Jia, Qing-ling Meng, Xue-ting Fan, Rui-guang Tian, Jonathan Audet, Xiang-guo Qiu & Sheng-li Bi. (2018) Intranasal vaccination with ebola virus GP amino acids 258–601 protects mice against lethal challenge. Vaccine 36:41, pages 6053-6060.
Crossref
Heinz Feldmann, Friederike Feldmann & Andrea Marzi. (2018) Ebola: Lessons on Vaccine Development. Annual Review of Microbiology 72:1, pages 423-446.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.